Fang T, Hu S, Song X, Wang J, et al. Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways. Breast Cancer Res Treat 2024 Jul 3. doi: 10.1007/s10549-024-07374.
PMID: 38958784